Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Express Scripts
Argus Health
Healthtrust
QuintilesIMS
Cipla
AstraZeneca
Harvard Business School
Medtronic
Moodys

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050155

« Back to Dashboard

NDA 050155 describes CHLOROMYCETIN, which is a drug marketed by Parke Davis and Parkedale and is included in seven NDAs. Additional details are available on the CHLOROMYCETIN profile page.

The generic ingredient in CHLOROMYCETIN is chloramphenicol; hydrocortisone acetate. There are fourteen drug master file entries for this compound. Additional details are available on the chloramphenicol; hydrocortisone acetate profile page.
Summary for 050155
Tradename:CHLOROMYCETIN
Applicant:Parkedale
Ingredient:chloramphenicol sodium succinate
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 1GM BASE/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Cantor Fitzgerald
Citi
US Army
Deloitte
Express Scripts
Queensland Health
UBS
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot